(Q38494605)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

review article

1 reference

title

Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author

Mohamed Kamel Soliman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Mohammad Ali Sadiq

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Aniruddha Agarwal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Mostafa Hanout

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Salman Sarwar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Diana V Do

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Quan Dong Nguyen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

20 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

1147-1156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

Clinical review: Update on treatment of inflammatory macular edema

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Diabetic macular edema: New promising therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Vascular endothelial growth factor inhibition in uveitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

General pathophysiology of macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Economic considerations of macular edema therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Fluocinolone acetonide intravitreal implant (Iluvien®): in diabetic macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Diabetic retinopathy and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Immunosuppressive drug use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Clinical trials on corticosteroids for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1041916

10.1517/14740338.2015.1041916

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25994877%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference